Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morris Sherman

Showing results (61-70 of 154) with videos related to

Pageof 16
Sort By:
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 8, 2011
Canadian patients with chronic hepatitis B cannot access appropriate drug treatments: a call for changeMorris Sherman, Samuel S Lee
Journal of the National Cancer Institute|October 25, 2011
Smoking, hepatitis B virus infection, and development of hepatocellular carcinomaMorris Sherman, Josep M Llovet
Canadian Journal of Gastroenterology & Hepatology|May 13, 2015
Hepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma MeetingKelly Warren Burak, Morris Sherman
Journal of Hepatology|November 10, 2015
Capitalising on improved rates of diagnosis of early hepatocellular carcinomaIan A Rowe, Morris Sherman
Gastroenterology|March 31, 2018
Why Won't the Alpha-fetoprotein Test Go Gentle Into the Good Night?Samuel S Lee, Morris Sherman
Gastroenterology|January 23, 2016
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular CarcinomaJordi Bruix, Maria Reig, Morris Sherman
The American Journal of Gastroenterology|June 30, 2005
Outcome of small (10-20 mm) arterial phase-enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver diseaseMartin E O'Malley, Yuji Takayama, Morris Sherman
Hepatology (Baltimore, Md.)|March 3, 2015
Risk scores for hepatocellular carcinoma in chronic hepatitis BMorris Sherman, Ray W Kim, James Dziura
Hepatology (Baltimore, Md.)|September 13, 2016
ReplySasan Roayaie, Morris Sherman, Lewis R Roberts
Hepatology (Baltimore, Md.)|June 13, 2012
Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendationsMorris Sherman, Jordi Bruix, Michael Porayko, et al.
Pageof 16

Showing results (61-70 of 154) with videos related to

Sort By:
Pageof 16
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 8, 2011
Canadian patients with chronic hepatitis B cannot access appropriate drug treatments: a call for changeMorris Sherman, Samuel S Lee
Journal of the National Cancer Institute|October 25, 2011
Smoking, hepatitis B virus infection, and development of hepatocellular carcinomaMorris Sherman, Josep M Llovet
Canadian Journal of Gastroenterology & Hepatology|May 13, 2015
Hepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma MeetingKelly Warren Burak, Morris Sherman
Journal of Hepatology|November 10, 2015
Capitalising on improved rates of diagnosis of early hepatocellular carcinomaIan A Rowe, Morris Sherman
Gastroenterology|March 31, 2018
Why Won't the Alpha-fetoprotein Test Go Gentle Into the Good Night?Samuel S Lee, Morris Sherman
Gastroenterology|January 23, 2016
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular CarcinomaJordi Bruix, Maria Reig, Morris Sherman
The American Journal of Gastroenterology|June 30, 2005
Outcome of small (10-20 mm) arterial phase-enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver diseaseMartin E O'Malley, Yuji Takayama, Morris Sherman
Hepatology (Baltimore, Md.)|March 3, 2015
Risk scores for hepatocellular carcinoma in chronic hepatitis BMorris Sherman, Ray W Kim, James Dziura
Hepatology (Baltimore, Md.)|September 13, 2016
ReplySasan Roayaie, Morris Sherman, Lewis R Roberts
Hepatology (Baltimore, Md.)|June 13, 2012
Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendationsMorris Sherman, Jordi Bruix, Michael Porayko, et al.
Pageof 16